MedTrace Logo

Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure

NCT03443479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2020-07-28

No results posted yet for this study

Summary

A retrospective cohort study of all patients treated for type II (hypercapnic) respiratory failure with either High-Flow Oxygen Therapy or Non-Invasive Ventilation in a general adult hospital.

Conditions

Interventions

DEVICE

Non-Invasive Ventilation

Treatment with Non-Invasive Ventilation by BiPAP. Different BiPAP models are in use. Ventilation parameters set at the discretion of the treating physician.

DEVICE

High-Flow Nasal Cannula

Treatment with a High-Flow Nasal Cannula. The Optiflow device by Fisher\&Paykel used in all cases. Flow and fraction of inspired oxygen (FiO2) parameters at the discretion of the treating physician.

Sponsors & Collaborators

  • Hôpital de Verdun

    lead OTHER

Principal Investigators

  • Ivan Pavlov, MD · Ivan Pavlov MD CP inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2019-07-01
Completion
2019-07-01
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443479 on ClinicalTrials.gov